Cite
HARVARD Citation
Moura, F. et al. (n.d.). Effects of dapagliflozin on cardiovascular and kidney events by baseline eGFR and UACR in patients with type 2 diabetes mellitus: a patient-level pooled analysis of DECLARE-TIMI 58 and DAPA-CKD trials. European heart journal. p. . [Online].